Rankings
▼
Calendar
EW Q4 2016 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena
EW
Edwards Lifesciences Corporation
$49B
Q4 2016 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$768M
Gross Profit
$557M
72.6% margin
Operating Income
$209M
27.2% margin
Net Income
$159M
20.6% margin
EPS (Diluted)
$0.24
QoQ Revenue Growth
+3.8%
Cash Flow
Operating Cash Flow
$201M
Free Cash Flow
$138M
Stock-Based Comp.
$14M
Balance Sheet
Total Assets
$4.5B
Total Liabilities
$1.9B
Stockholders' Equity
$2.6B
Cash & Equivalents
$930M
Revenue Segments
Transcatheter Heart Valves
$432M
56%
Surgical Heart Valve Therapy
$189M
25%
Critical Care
$146M
19%
Geographic Segments
UNITED STATES
$422M
55%
Europe
$185M
24%
JAPAN
$83M
11%
Rest of World
$79M
10%
← FY 2016
All Quarters
Q1 2017 →
